Literature DB >> 30903231

MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.

Patricia Balcacer1, Arvind Shergill2, Babak Litkouhi3.   

Abstract

LEARNING
OBJECTIVES: Magnetic resonance imaging (MRI) of the pelvis is the most reliable imaging modality for staging, treatment planning, and follow-up of cervical cancer; and its findings may now be incorporated into the International Federation of Gynecology and Obstetrics Federation (FIGO) 2018 clinical staging of cervical cancer. It is imperative that radiologists are familiar with the imaging appearance of the different stages of cervical cancer as well as the post-treatment changes and imaging pitfalls given the respective clinical manifestations, treatment regimens, and prognosis of an accurate diagnosis. In addition to the different stages of cervical cancer, we address the imaging techniques for diagnosis, staging and treatment implications as well as the changes of the new FIGO staging system.
BACKGROUND: The use of MRI to diagnose and stage cervical cancer is steadily increasing and the new FIGO stagi ng system, previously based on clinical examination, now allows the staging or change of staging based on the imaging findings. MRI can evaluate the extent of disease because of its excellent contrast resolution for pelvic tissues and organs, high accuracy and detailed elaboration of the cervical/uterovaginal anatomy. CONTENT: Relevant anatomy, including normal MRI appearance of the cervix, parametria and pelvic ligaments; different stages of cervical cancer on MRI with prognostic and therapeutic implications; MRI sequences, other imaging modalities used in the staging and follow-up, treatment of different stages and the appearance of the cervix and cervical cancer post-treatment. Since clinical implications and therapeutic strategies for cervical cancer treatment vary tremendously according to degree of tumor extension, familiarity with relevant MRI techniques and findings is essential for radiologists. It is important that radiologists interpreting pelvic MRI are aware with the different stages of cervical cancer to provide useful information regarding treatment and prognosis. Pitfalls regarding the interpretation of tumor extension can interfere with an accurate diagnosis and have significant therapeutic implications.

Entities:  

Keywords:  Cervical cancer; Cervical cancer staging; FIGO cervical staging

Year:  2019        PMID: 30903231     DOI: 10.1007/s00261-019-01984-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  12 in total

1.  The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.

Authors:  Ying Liu; Jun Hua; Lisheng Liu; Wei Zhang; Shufan Xu; Xiaoliang Chen
Journal:  Nucl Med Commun       Date:  2022-08-25       Impact factor: 1.698

2.  The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.

Authors:  Zhimin He; Rongsheng Chen; Shangying Hu; Yajiao Zhang; Yang Liu; Chengwei Li; Fajin Lv; Zhibo Xiao
Journal:  BMC Cancer       Date:  2022-07-15       Impact factor: 4.638

Review 3.  Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer.

Authors:  Siaw Shi Boon; Ho Yin Luk; Chuanyun Xiao; Zigui Chen; Paul Kay Sheung Chan
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

4.  Development of a Deep Learning Model to Identify Lymph Node Metastasis on Magnetic Resonance Imaging in Patients With Cervical Cancer.

Authors:  Qingxia Wu; Shuo Wang; Shuixing Zhang; Meiyun Wang; Yingying Ding; Jin Fang; Qingxia Wu; Wei Qian; Zhenyu Liu; Kai Sun; Yan Jin; He Ma; Jie Tian
Journal:  JAMA Netw Open       Date:  2020-07-01

5.  Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

Authors:  Hideaki Tsuyoshi; Tetsuya Tsujikawa; Shizuka Yamada; Hidehiko Okazawa; Yoshio Yoshida
Journal:  Diagnostics (Basel)       Date:  2021-01-29

6.  Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.

Authors:  Chao Ran; Jian Sun; Yunhui Qu; Na Long
Journal:  World J Surg Oncol       Date:  2021-12-09       Impact factor: 2.754

7.  Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.

Authors:  Liying Liu; Shuo Wang; Tao Yu; Haoyan Bai; Jingyu Liu; Danbo Wang; Yahong Luo
Journal:  Ann Transl Med       Date:  2022-01

8.  Diagnosis of Early Cervical Cancer with a Multimodal Magnetic Resonance Image under the Artificial Intelligence Algorithm.

Authors:  Zhenge Zhang; Chongyuan Zhang; Li Xiao; Shuirong Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-03-23       Impact factor: 3.161

9.  Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer.

Authors:  Kari S Wagner-Larsen; Njål Lura; Øyvind Salvesen; Mari Kyllesø Halle; David Forsse; Jone Trovik; Noeska Smit; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Eur Radiol       Date:  2022-03-24       Impact factor: 7.034

Review 10.  Radiomics in cervical and endometrial cancer.

Authors:  Lucia Manganaro; Gabriele Maria Nicolino; Miriam Dolciami; Federica Martorana; Anastasios Stathis; Ilaria Colombo; Stefania Rizzo
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.